Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Long-Term Investments

Acadia Pharmaceutica Long-Term Investments Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Long-Term Investments from 2018 to 2020.
  • Acadia Pharmaceutica Long-Term Investments for the quarter ending June 06, 2020 was $1m a -50.00% decrease of -1m year over year
  • Acadia Pharmaceutica Long-Term Investments for the last 12 months ending June 06, 2020 was $1m a -50.00% decrease of -1m year over year
  • Acadia Pharmaceutica Annual Long-Term Investments for 2019 was $2m a 43.48% increase of 1m from 2018
  • Acadia Pharmaceutica Annual Long-Term Investments for 2018 was $1m
Other Cash Flow Metrics:
  • Acadia Pharmaceutica Cash Flow from Operations for the quarter ending September 09, 2018 was $-42m a 29.29% decrease of -12m year over year
  • Acadia Pharmaceutica Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-22m a 80.38% decrease of -17m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Long-Term Investments Data

06/2020$1m
03/2020$1m
12/2019$2m
09/2019$2m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$3m

Annual ACAD Long-Term Investments Data

2019$2m
2018$1m